Jump to content

Page values for "Nabumetone"

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringNabumetone
brandStringRelafen
structureFile
classesList of String, delimiter: ,[[:Category:NSAIDs|Non-steroidal anti-inflammatory drug (NSAID)]] [[:Category:Acetic_acid_derivatives|Acetic acid derivative]]
mechanismString'"`UNIQ--vote-000011F4-QINU`"' Like all NSAIDs, raises CV thrombotic risk modestly (FDA 2014/2015 advisory) and produces GI, renal, hypertensive, and platelet-inhibitory effects characteristic of the class'"`UNIQ--ref-000011F5-QINU`"'.
usesString'"`UNIQ--vote-000011F6-QINU`"', '"`UNIQ--vote-000011F7-QINU`"', '"`UNIQ--vote-000011F8-QINU`"'
starting_doseString1000 mg PO once daily; 500-2000 mg/d in single or divided doses
preparationsString500, 750 mg tablets
fda_maxString2000 mg/d
pill_idText
routesList of String, delimiter: ,Oral
onsetStringAnalgesia within hours; anti-inflammatory effect over days
durationString24 hours
halflifeString~24 hours (6-methoxy-2-naphthylacetic acid, the active metabolite)'"`UNIQ--ref-000011F9-QINU`"'
bioavailabilityString~38% (oral; non-acidic prodrug improves GI tolerability over many other NSAIDs)'"`UNIQ--ref-000011FA-QINU`"'
pregnancyStringAvoid after 20 weeks (NSAID-class FDA 2020 advisory on fetal renal injury and oligohydramnios with second/third-trimester use).<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString[[USLegal:Prescription only|Rx-only]] in US. Carries the NSAID-class '''Boxed Warning''' for cardiovascular thrombotic events and serious GI bleeding'"`UNIQ--ref-000011FB-QINU`"'